Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

2.

Atypical antipsychotics for disruptive behaviour disorders in children and youths.

Loy JH, Merry SN, Hetrick SE, Stasiak K.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD008559. doi: 10.1002/14651858.CD008559.pub2. Review.

PMID:
22972123
3.

Efficacy of atypical antipsychotics in elderly patients with dementia.

Tariot PN, Profenno LA, Ismail MS.

J Clin Psychiatry. 2004;65 Suppl 11:11-5. Review.

4.

The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.

Ballard C, Waite J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003476. Review.

PMID:
16437455
5.

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

Schneider LS, Dagerman K, Insel PS.

Am J Geriatr Psychiatry. 2006 Mar;14(3):191-210.

PMID:
16505124
6.

Increase in mortality rate in patients with dementia treated with atypical antipsychotics: a cohort study in outpatients in Central Italy.

Piersanti M, Capannolo M, Turchetti M, Serroni N, De Berardis D, Evangelista P, Costantini P, Orsini A, Rossi A, Maggio R.

Riv Psichiatr. 2014 Jan-Feb;49(1):34-40. doi: 10.1708/1407.15623.

PMID:
24572582
8.
9.

Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara.

Chiabrando G, Bianchi S, Poluzzi E, Montanaro N, Scanavacca P.

Eur J Clin Pharmacol. 2010 Jul;66(7):661-9. doi: 10.1007/s00228-010-0828-z.

PMID:
20464383
10.

Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.

Vigen CL, Mack WJ, Keefe RS, Sano M, Sultzer DL, Stroup TS, Dagerman KS, Hsiao JK, Lebowitz BD, Lyketsos CG, Tariot PN, Zheng L, Schneider LS.

Am J Psychiatry. 2011 Aug;168(8):831-9. doi: 10.1176/appi.ajp.2011.08121844.

12.

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, Lebowitz BD, Lyketsos CG, Ryan JM, Stroup TS, Sultzer DL, Weintraub D, Lieberman JA; CATIE-AD Study Group..

N Engl J Med. 2006 Oct 12;355(15):1525-38.

13.

Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.

Finkel S, Kozma C, Long S, Greenspan A, Mahmoud R, Baser O, Engelhart L.

Int Psychogeriatr. 2005 Dec;17(4):617-29.

PMID:
16202186
14.

Antipsychotics for delirium.

Lonergan E, Britton AM, Luxenberg J, Wyller T.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005594. Review.

PMID:
17443602
15.

Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.

Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, Christiaens T.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD007726. doi: 10.1002/14651858.CD007726.pub2. Review.

PMID:
23543555
16.

Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.

Maust DT, Kim HM, Seyfried LS, Chiang C, Kavanagh J, Schneider LS, Kales HC.

JAMA Psychiatry. 2015 May;72(5):438-45. doi: 10.1001/jamapsychiatry.2014.3018.

17.

Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.

Marras C, Herrmann N, Anderson GM, Fischer HD, Wang X, Rochon PA.

Am J Geriatr Pharmacother. 2012 Dec;10(6):381-9. doi: 10.1016/j.amjopharm.2012.11.001.

PMID:
23217531
18.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311
19.

Typical and atypical antipsychotics in bipolar depression.

Gao K, Gajwani P, Elhaj O, Calabrese JR.

J Clin Psychiatry. 2005 Nov;66(11):1376-85. Review.

PMID:
16420074
20.
Items per page

Supplemental Content

Support Center